DR. RICHARD A KASLOW, M.D., M.P.H.
Medical Practice at University Blvd, Birmingham, AL
License number
Alabama 20334
Category
Osteopathic Medicine
Type
Infectious Disease
License number
Alabama 20334
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
1665 University Blvd, Birmingham, AL 35294
Phone
(205) 975-8698
(205) 934-8665 (Fax)
(205) 934-8665 (Fax)
Personal information
See more information about RICHARD A KASLOW at radaris.comName
Address
Phone
2906 Berwick Rd, Birmingham, AL 35213
Organization information
See more information about RICHARD A KASLOW at bizstanding.comRichard Kaslow MD,MPH
1665 University Blvd, Birmingham, AL 35294
Industry:
Internist
Phone:
(205) 975-8698 (Phone)
Richard Alan Kaslow
Uab School Of Public Health - Richard A Kaslow MD
1665 University Blvd #RPHB220A, Birmingham, AL 35233
Categories:
Allied Health Education, Natural Health Education
Phone:
(205) 975-8698 (Phone)
Professional information
Dr. Richard A Kaslow, Birmingham AL - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
1665 University Blvd, Birmingham 35233
(205) 975-8698 (Phone), (205) 934-8665 (Fax)
(205) 975-8698 (Phone), (205) 934-8665 (Fax)
Certifications:
General Preventive Medicine, Infectious Disease, 1984, Internal Medicine, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1969
Mount Sinai Hospital
U Calif Hosps
Beth Israel Chldns Hosp Med
Harvard Medical School
Graduated: 1969
Mount Sinai Hospital
U Calif Hosps
Beth Israel Chldns Hosp Med
Methods Of Surveying For Cc (Beta) Chemokine Receptor Variants And Their Association With Hiv-1 Transmission And/Or Disease Progression
US Patent:
6372435, Apr 16, 2002
Filed:
Aug 11, 2000
Appl. No.:
09/638509
Inventors:
Richard A. Kaslow - Birmingham AL
Jianming Tang - Birmingham AL
Jianming Tang - Birmingham AL
Assignee:
UAB Research Foundation - Birmingham AL
International Classification:
C12Q 168
US Classification:
435 6, 435 5, 435 911, 435 912, 514329, 544188, 544193, 544209, 544214, 544222, 544223
Abstract:
The present invention provides methods of correlating genetic variants in the beta-chemokine receptor 5 (CCR5) locus, more specifically CCR5 promoter alleles and genotypes, with HIV-1 transmission and/or disease progression in individuals and populations.
Cytotoxic T-Lymphocyte Antigen-4 Or Interleukin-10 Polymorphisms As Predictors Of Response To Therapeutic Intervention
US Patent:
2004017, Sep 2, 2004
Filed:
Feb 25, 2004
Appl. No.:
10/469277
Inventors:
Leland Yee - Pittsburgh PA, US
Jianming Tang - Birmingham AL, US
Richard Kaslow - Birmingham AL, US
Dirk van Leeuwen - Birmingham AL, US
Jianming Tang - Birmingham AL, US
Richard Kaslow - Birmingham AL, US
Dirk van Leeuwen - Birmingham AL, US
International Classification:
C12Q001/70, C12Q001/68
US Classification:
435/006000, 435/005000
Abstract:
A composition and process are provided for predicting the responsiveness of an individual to therapy for a pathological condition is based on detecting nucleic acid allele sequences in an interleukin-10 regulatory region or cytotoxic t-lymphocyte antigen-4 promoter or exon region of the individual. The detected nucleic acid allele is then associated with the level of therapeutic responsiveness to a pathological condition based upon genotype. Comparison across multiple alleles and regions improves the predictive nature of the process.